Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-11-06
2007-11-06
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253090, C544S363000, C544S373000
Reexamination Certificate
active
10466121
ABSTRACT:
The present invention relates to melanocortin receptor agonists of formula (I), which is useful in the treatment of obesity, diabetes and male and/or female sexual dysfunction
REFERENCES:
patent: 6294534 (2001-09-01), Nargund et al.
patent: 7115607 (2006-10-01), Fotsch et al.
patent: 7186715 (2007-03-01), Briner et al.
patent: 2003/0220324 (2003-11-01), Fotsch et al.
patent: WO 94 13696 (1994-06-01), None
patent: WO 99 55679 (1999-11-01), None
patent: WO 99 64002 (1999-12-01), None
patent: WO 00 74679 (2000-12-01), None
patent: WO 01 70337 (2001-09-01), None
patent: WO 01 70708 (2001-09-01), None
patent: WO 02 15909 (2002-02-01), None
patent: WO 02 059095 (2002-08-01), None
patent: WO 02 059107 (2002-08-01), None
patent: WO 02 059117 (2002-08-01), None
patent: WO 02 070511 (2002-09-01), None
Sebhat et al. Annual Reports in medicinal Chemistry, vol. 38,p. 31-40 (2003).
Campfield et al. Science, vol. 280, p. 1383-1387 (1998).
Biggers Christopher Kelly
Briner Karin
Doecke Christopher William
Fisher Matthew Joseph
Hertel Larry Wayne
Bernhardt Emily
Eli Lilly and Company
Jang Soonhee
Myers James B.
LandOfFree
Melanocortin receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Melanocortin receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanocortin receptor agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3828890